Trademark Overview
On Thursday, June 5, 2025, a trademark application was filed for GREXSLO with the United States Patent and Trademark Office. The USPTO has given the GREXSLO trademark a serial number of 79427050. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, July 3, 2025. This trademark is owned by BIAL - R&D INVESTMENTS, S.A.. The GREXSLO trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical products and preparations for the prevention and treatment of lysosomal storage disorders, in particular Gaucher Disease, as well as of diseases and disorders affecting the central and peripheral nervous systems, including movement disorders, Parkinson's disease, and related parkinsonian conditions.